# Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

> **NCT02104440** · PHASE2 · COMPLETED · sponsor: **Red de Terapia Celular** · enrollment: 15 (actual)

## Conditions studied

- Cytopenia

## Interventions

- **BIOLOGICAL:** Sequential infusion of allogeneic mesenchymal stem cells expanded "in vitro"

## Key facts

- **NCT ID:** NCT02104440
- **Lead sponsor:** Red de Terapia Celular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104440, "Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02104440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*